Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says

FILE - A woman holds up a dosage of Wegovy, a drug used for weight loss, at her home in Front Royal, Va., on March 1, 2024. (AP Photo/Amanda Andrade-Rhoades, File)

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the popular diabetes and obesity treatments continue to improve, federal regulators said Friday.

The drugmaker Novo Nordisk can meet current and future demand in the U.S., the Food and Drug Administration said. But patients may still see some supply disruptions as the medications move from the manufacturer to distributors and then to pharmacies.

The ºÃÉ«tv Press. All rights reserved.

More Health Stories

Sign Up to Newsletters

Get the latest from ºÃÉ«tvNews in your inbox. Select the emails you're interested in below.